DGX is Quest Diagnostics Incorporated (Healthcare). Trading at $195.21. Current dividend yield: 1.76%.
Dividend snapshot
| Annual dividend rate | $3.44 |
| Current yield | 1.76% |
| Payment frequency | Quarterly |
| Next ex-dividend date | Jul 08, 2026 |
| Most recent payment date | Apr 20, 2026 |
| Last payment amount | $0.8600 |
| 5-year dividend CAGR | 7.35% |
| 3-year dividend CAGR | 6.61% |
| Payout ratio | 36% |
| Market cap | $21.61B |
| Exchange | NYQ |
Recent dividend payments
| Date | Amount / share |
|---|---|
| 2026-04-06 | $0.8600 |
| 2026-01-13 | $0.8000 |
| 2025-10-03 | $0.8000 |
| 2025-07-07 | $0.8000 |
| 2025-04-07 | $0.8000 |
| 2025-01-14 | $0.7500 |
| 2024-10-04 | $0.7500 |
| 2024-07-08 | $0.7500 |
About DGX
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Track DGX in DiviDrip
Add DGX to your portfolio on DiviDrip to track every buy, DRIP reinvestment, and dividend payment in one place. Free, no credit card, no upsell — built by dividend investors, for dividend investors.
- Open DiviDrip — search DGX and add your shares.
- View the DGX Dividend Triangle — see Revenue × EPS × Dividend growth at a glance.
- Stock Screener — find more dividend payers like DGX.
- DiviDrip Learn — free guides on DRIP, dividend tiers, ETF comparisons.
Data refreshed 2026-05-24. Not investment advice. Yields and prices change continuously; always verify the latest numbers in the live app before buying.